Global Infant Formula Market Overview

Global Infant Formula Market was valued at USD 68.15 billion in 2021 and is expected to reach USD 137.09 billion by the year 2028, at a CAGR of 10.5%.

Infant formula is nothing but the baby formula that has a high nutritional value such as carbohydrates, vitamins, proteins, fats, and minerals. Infant formula is manufactured food that is used as an alternative to human breast milk. This formula is produced for the infant for their overall development and supplies crucial nutrients to the baby in the initial phase of development. Infant formula is suitable for babies below 12 months of age. Furthermore, the increase in the infant formula market is significantly driven by the growth in the number of working women. For instance, according to the World Bank, the percentage of women's workforce raised by 4% across the globe between 1990 to 2013. Currently, many working mothers started their work shortly after giving birth. In such a scenario, manufactured infant formulas and foods provide an attractive substitute to working mothers, fulfilling their requirements for healthy and nutritious food for their infants.

Moreover, many common reasons for preferring formula-feeding such as an insufficient supply of maternal breast milk, inadequate sucking by the baby, incapacity to quantitate the precise amount of breast milk received by the infant. Additionally, awareness about transferring drugs the mother may be taking for a health problem by the breast milk to the infant leads the preferring for the infant formulas and helps to growth of the market during the forecast period.

COVID-19 Impact on Infant Formula Market

The Growing cases of COVID–19 is anticipated to have a short-term adverse impact on the export-import of the nutrition sector. The short-term impact on the infant formula segment is less important, nevertheless, the negative impact of COVID-19 on the global economy can have remarkedly indirect effects on the infant formula nutrition segment of the market. The healthcare facilities, such as market players and the government, are investing heavily in controlling the supply of required nutrition and food. Most infant formula producers were found targeting ramping up the production of infant food to ensure availability.

The American Academy of Pediatrics (AAP) also suggested that during the COVID-19 pandemic, individuals should buy no more than 10 days to 2 weeks supply of formula to ensure the availability of formulas to everyone. Furthermore, there have been unrivaled differentiations in the global sales of infant formula and food products due to the switching in purchase patterns among individuals. Growing trends of bulk buying and stockpiling of infant formula or foods have led to certain products being in very lower supply, which in turn has led to price variations in the global infant formula market. This scenario is anticipated to hamper the infant formula market globally.

Market Dynamics and Factors

Drivers:

A growing number of working women populations is a key factor driving the market growth of infant formula. Several women resume their jobs quickly after delivery and infant formula is perfect for these women as it is easy to make and consumes lesser time. Furthermore, infant formula has numerous nutritional values that are present in human breast milk which is further increasing their incorporation among individuals.

Growing consciousness associated with the factors affecting infants' health and the advantages of micronutrients in promoting growth is motivating key players to launch animal-free and organic products. Consumers are becoming more aware related to their purchasing decisions concerning infant formula, with rising curiosity about the usage of different ingredients in these products.

An increasing birth rate across emerging regions is anticipated to boost the market growth of infant formula. For instance, according to the Population Reference Bureau, the global population in 2015 was 7.3 billion and is estimated to grow to 9.8 billion by 2050. This will help the market growth in the upcoming years. Additionally, the two-child policy in China as long as 1 January 2016 is further anticipated to augment the market growth during the forecast period.

Restraints:

Stringent regulatory obstacle related with the approval for production of infant's formula and food is anticipated to hamper the market growth of infant formula. Furthermore, the rising prevalence of scandals in the infant formula industry is again expected to influence the market growth poorly. Lack of awareness associated with the health benefits of infant formula among individuals of emerging countries primarily across rural areas is projected to restrain the market growth of infant formula.

Opportunities:

Rising demand for premium infant nutrition products is anticipated to offer lucrative opportunities to the market of infant formula. For example, in November 2019, Advanced Lipids has introduced two latest additions to its infant range of infant formula substances. A new exclusive catering, such as Infant Pro, provides higher levels of sn-2 palmitate, another Infant MF is a special blend including milk fat. Both new segments will be revealed at Food Ingredients Europe, 3-5 December in Paris.

An increase in the online retail industry all over the world which enables easy purchasing of products at a reasonable rate with convenience is anticipated to create new opportunities to the market of infant formula. Working women highly favor online shopping owing to their busy lifestyles. Hence, growth in the online retail industry over emerging regions is anticipated to upsurge the market growth in upcoming years.

Market Segmentation

Segmentation Insights

Based on Product Type, follow on milk formula accounted for the largest market share owing to the ability of preimmunized follow on milk to imitate the nutritive function of breast milk owing to rich in protein, calcium, iron, and other micronutrient content is anticipated to accelerate the infant formula market share of the product.

Based on Source, the cow milk segment is projected to register the largest market share during the forecast period due to its acceptance as a cost-effective manufacturing process, and cow milk-based ingredients are available in bulk. Besides this, Johnson & Company, LLC (US), Nestlé S.A. (Switzerland), Abbott Laboratories (US), and Mead are key producers of infant formula are use cow-based milk.

Based on Form, the powder form segment dominates the market over the forecast period. Infant formula substance is generally utilized in the powdered form, due to its ease of handling compared to liquid infant formula substance. Various kinds of infant formula substances such as proteins, carbohydrates, some fats, and prebiotics are commonly used in powdered form by infant formula producers. Therefore, high growth expectations lie ahead for powder infant formula producers in the coming years, especially from developing countries.

Based on Distribution Channels, hypermarkets/supermarkets are projected to account for the largest market share during the forecast period. The mass merchandisers offer improved convenience, separate baby sections, various offers, schemes, and convenient shopping experiences to the customer under one roof. Thus, such a distribution channel is anticipated to act as a "one-stop-for-all" regarding infant formula.

Regional Insights

North America region dominates infant formula market during the forecast period. Key factors responsible to hold maximum share such as high disposable income, presence of major players in the region, and well-developed pharmaceutical and biotechnology sectors are imputed to the growth of the market in the region.

Europe is the second-largest market for infant formula due to good production facilities and the high spending power and disposal income on infants and per baby.

Asia Pacific region is anticipated the significant growth rate during the forecast period. The high baby boomer population, growing disposable income, and rapid urbanization contribute to the growth of the market in the Asia Pacific. Furthermore, the slowdown in sales in developed regions has impelled leading players to focus on developing markets. China's large population base and rapidly increasing volume of consumers with rising purchasing power is very attractive to foreign brands, thus, the 2008 melamine infant formula issue still overshadows the market and has produced an environment where consumers are conscious of the health and safety of infant formula.

Key Industry Developments

• In January 2021, Fats and oils Specialist and Netherland based company, Bunge Loders Croklaan (BLC), declared the introduction of a new premium lipid ingredient for a baby formula which claims to be a replica of mother's milk to taste, nutrition, and has a natural balance.
• In March 2021, 108LABS revealed its new animal-free infant baby formula, Colostrupedis, which consists of cell-cultured human milk molecules discovered from human mammary cell agriculture and formulated with broadly neutralizing human secretory antibodies.

Players Covered in Infant Formula market are :

• Abbott Nutrition
• The Kraft Heinz Company
• Nestle S. A
• FrieslandCampina N.V. Group
• Danone S.A.
• Synutra International Inc.
• Mead Johnson Nutrition
• Meiji Holdings Co. Ltd.
• Beingmate Baby & Child Food Co. Ltd.
• Pfizer Inc
• Yili Group
• Bellamy's Organic
• Aral Foods Amba and other major players.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Source
 3.3 By Form
 3.4 By Distribution Channels

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Infant Formula Market by Product Type
 5.1 Infant Formula Market Overview Snapshot and Growth Engine
 5.2 Infant Formula Market Overview
 5.3 First Infant Formula
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 First Infant Formula: Grographic Segmentation
 5.4 Follow-on Formula
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Follow-on Formula: Grographic Segmentation
 5.5 Growing-up Formula
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Growing-up Formula: Grographic Segmentation
 5.6 Specialty Baby Formula
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Specialty Baby Formula: Grographic Segmentation

Chapter 6: Infant Formula Market by Source
 6.1 Infant Formula Market Overview Snapshot and Growth Engine
 6.2 Infant Formula Market Overview
 6.3 Cow Milk
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cow Milk: Grographic Segmentation
 6.4 Soy
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Soy: Grographic Segmentation
 6.5 Protein Hydrolysates
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Protein Hydrolysates: Grographic Segmentation
 6.6 Goat Milk
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Goat Milk: Grographic Segmentation
 6.7 Camel Milk
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Camel Milk: Grographic Segmentation
 6.8 Others
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size (2016-2028F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Others: Grographic Segmentation

Chapter 7: Infant Formula Market by Form
 7.1 Infant Formula Market Overview Snapshot and Growth Engine
 7.2 Infant Formula Market Overview
 7.3 Powder
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Powder: Grographic Segmentation
 7.4 Liquid & Semi-Liquid
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Liquid & Semi-Liquid: Grographic Segmentation
 7.5 Ready-To-Drink
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Ready-To-Drink: Grographic Segmentation

Chapter 8: Infant Formula Market by Distribution Channels
 8.1 Infant Formula Market Overview Snapshot and Growth Engine
 8.2 Infant Formula Market Overview
 8.3 Hypermarkets/Supermarkets
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hypermarkets/Supermarkets: Grographic Segmentation
 8.4 Online Stores
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Online Stores: Grographic Segmentation
 8.5 Pharmacy/Medical Stores
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Pharmacy/Medical Stores: Grographic Segmentation
 8.6 Specialty Stores
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Specialty Stores: Grographic Segmentation
 8.7 Others
  8.7.1 Introduction and Market Overview
  8.7.2 Historic and Forecasted Market Size (2016-2028F)
  8.7.3 Key Market Trends, Growth Factors and Opportunities
  8.7.4 Others: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Infant Formula Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Infant Formula Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Infant Formula Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 ABBOTT NUTRITION
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 THE KRAFT HEINZ COMPANY
 9.4 NESTLE S. A
 9.5 FRIESLANDCAMPINA N.V. GROUP
 9.6 DANONE S.A.
 9.7 SYNUTRA INTERNATIONAL INC.
 9.8 MEAD JOHNSON NUTRITION
 9.9 MEIJI HOLDINGS CO. LTD.
 9.10 BEINGMATE BABY & CHILD FOOD CO. LTD.
 9.11 PFIZER INC
 9.12 YILI GROUP
 9.13 BELLAMY'S ORGANIC
 9.14 ARAL FOODS AMBA
 9.15 OTHER MAJOR PLAYERS

Chapter 10: Global Infant Formula Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Product Type
  10.2.1 First Infant Formula
  10.2.2 Follow-on Formula
  10.2.3 Growing-up Formula
  10.2.4 Specialty Baby Formula
 10.3 Historic and Forecasted Market Size By Source
  10.3.1 Cow Milk
  10.3.2 Soy
  10.3.3 Protein Hydrolysates
  10.3.4 Goat Milk
  10.3.5 Camel Milk
  10.3.6 Others
 10.4 Historic and Forecasted Market Size By Form
  10.4.1 Powder
  10.4.2 Liquid & Semi-Liquid
  10.4.3 Ready-To-Drink
 10.5 Historic and Forecasted Market Size By Distribution Channels
  10.5.1 Hypermarkets/Supermarkets
  10.5.2 Online Stores
  10.5.3 Pharmacy/Medical Stores
  10.5.4 Specialty Stores
  10.5.5 Others

Chapter 11: North America Infant Formula Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 First Infant Formula
  11.4.2 Follow-on Formula
  11.4.3 Growing-up Formula
  11.4.4 Specialty Baby Formula
 11.5 Historic and Forecasted Market Size By Source
  11.5.1 Cow Milk
  11.5.2 Soy
  11.5.3 Protein Hydrolysates
  11.5.4 Goat Milk
  11.5.5 Camel Milk
  11.5.6 Others
 11.6 Historic and Forecasted Market Size By Form
  11.6.1 Powder
  11.6.2 Liquid & Semi-Liquid
  11.6.3 Ready-To-Drink
 11.7 Historic and Forecasted Market Size By Distribution Channels
  11.7.1 Hypermarkets/Supermarkets
  11.7.2 Online Stores
  11.7.3 Pharmacy/Medical Stores
  11.7.4 Specialty Stores
  11.7.5 Others
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Infant Formula Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 First Infant Formula
  12.4.2 Follow-on Formula
  12.4.3 Growing-up Formula
  12.4.4 Specialty Baby Formula
 12.5 Historic and Forecasted Market Size By Source
  12.5.1 Cow Milk
  12.5.2 Soy
  12.5.3 Protein Hydrolysates
  12.5.4 Goat Milk
  12.5.5 Camel Milk
  12.5.6 Others
 12.6 Historic and Forecasted Market Size By Form
  12.6.1 Powder
  12.6.2 Liquid & Semi-Liquid
  12.6.3 Ready-To-Drink
 12.7 Historic and Forecasted Market Size By Distribution Channels
  12.7.1 Hypermarkets/Supermarkets
  12.7.2 Online Stores
  12.7.3 Pharmacy/Medical Stores
  12.7.4 Specialty Stores
  12.7.5 Others
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Infant Formula Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 First Infant Formula
  13.4.2 Follow-on Formula
  13.4.3 Growing-up Formula
  13.4.4 Specialty Baby Formula
 13.5 Historic and Forecasted Market Size By Source
  13.5.1 Cow Milk
  13.5.2 Soy
  13.5.3 Protein Hydrolysates
  13.5.4 Goat Milk
  13.5.5 Camel Milk
  13.5.6 Others
 13.6 Historic and Forecasted Market Size By Form
  13.6.1 Powder
  13.6.2 Liquid & Semi-Liquid
  13.6.3 Ready-To-Drink
 13.7 Historic and Forecasted Market Size By Distribution Channels
  13.7.1 Hypermarkets/Supermarkets
  13.7.2 Online Stores
  13.7.3 Pharmacy/Medical Stores
  13.7.4 Specialty Stores
  13.7.5 Others
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Infant Formula Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product Type
  14.4.1 First Infant Formula
  14.4.2 Follow-on Formula
  14.4.3 Growing-up Formula
  14.4.4 Specialty Baby Formula
 14.5 Historic and Forecasted Market Size By Source
  14.5.1 Cow Milk
  14.5.2 Soy
  14.5.3 Protein Hydrolysates
  14.5.4 Goat Milk
  14.5.5 Camel Milk
  14.5.6 Others
 14.6 Historic and Forecasted Market Size By Form
  14.6.1 Powder
  14.6.2 Liquid & Semi-Liquid
  14.6.3 Ready-To-Drink
 14.7 Historic and Forecasted Market Size By Distribution Channels
  14.7.1 Hypermarkets/Supermarkets
  14.7.2 Online Stores
  14.7.3 Pharmacy/Medical Stores
  14.7.4 Specialty Stores
  14.7.5 Others
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Infant Formula Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Product Type
  15.4.1 First Infant Formula
  15.4.2 Follow-on Formula
  15.4.3 Growing-up Formula
  15.4.4 Specialty Baby Formula
 15.5 Historic and Forecasted Market Size By Source
  15.5.1 Cow Milk
  15.5.2 Soy
  15.5.3 Protein Hydrolysates
  15.5.4 Goat Milk
  15.5.5 Camel Milk
  15.5.6 Others
 15.6 Historic and Forecasted Market Size By Form
  15.6.1 Powder
  15.6.2 Liquid & Semi-Liquid
  15.6.3 Ready-To-Drink
 15.7 Historic and Forecasted Market Size By Distribution Channels
  15.7.1 Hypermarkets/Supermarkets
  15.7.2 Online Stores
  15.7.3 Pharmacy/Medical Stores
  15.7.4 Specialty Stores
  15.7.5 Others
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. INFANT FORMULA MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. INFANT FORMULA MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. INFANT FORMULA MARKET COMPETITIVE RIVALRY
TABLE 005. INFANT FORMULA MARKET THREAT OF NEW ENTRANTS
TABLE 006. INFANT FORMULA MARKET THREAT OF SUBSTITUTES
TABLE 007. INFANT FORMULA MARKET BY PRODUCT TYPE
TABLE 008. FIRST INFANT FORMULA MARKET OVERVIEW (2016-2028)
TABLE 009. FOLLOW-ON FORMULA MARKET OVERVIEW (2016-2028)
TABLE 010. GROWING-UP FORMULA MARKET OVERVIEW (2016-2028)
TABLE 011. SPECIALTY BABY FORMULA MARKET OVERVIEW (2016-2028)
TABLE 012. INFANT FORMULA MARKET BY SOURCE
TABLE 013. COW MILK MARKET OVERVIEW (2016-2028)
TABLE 014. SOY MARKET OVERVIEW (2016-2028)
TABLE 015. PROTEIN HYDROLYSATES MARKET OVERVIEW (2016-2028)
TABLE 016. GOAT MILK MARKET OVERVIEW (2016-2028)
TABLE 017. CAMEL MILK MARKET OVERVIEW (2016-2028)
TABLE 018. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 019. INFANT FORMULA MARKET BY FORM
TABLE 020. POWDER MARKET OVERVIEW (2016-2028)
TABLE 021. LIQUID & SEMI-LIQUID MARKET OVERVIEW (2016-2028)
TABLE 022. READY-TO-DRINK MARKET OVERVIEW (2016-2028)
TABLE 023. INFANT FORMULA MARKET BY DISTRIBUTION CHANNELS
TABLE 024. HYPERMARKETS/SUPERMARKETS MARKET OVERVIEW (2016-2028)
TABLE 025. ONLINE STORES MARKET OVERVIEW (2016-2028)
TABLE 026. PHARMACY/MEDICAL STORES MARKET OVERVIEW (2016-2028)
TABLE 027. SPECIALTY STORES MARKET OVERVIEW (2016-2028)
TABLE 028. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 029. NORTH AMERICA INFANT FORMULA MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 030. NORTH AMERICA INFANT FORMULA MARKET, BY SOURCE (2016-2028)
TABLE 031. NORTH AMERICA INFANT FORMULA MARKET, BY FORM (2016-2028)
TABLE 032. NORTH AMERICA INFANT FORMULA MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 033. N INFANT FORMULA MARKET, BY COUNTRY (2016-2028)
TABLE 034. EUROPE INFANT FORMULA MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 035. EUROPE INFANT FORMULA MARKET, BY SOURCE (2016-2028)
TABLE 036. EUROPE INFANT FORMULA MARKET, BY FORM (2016-2028)
TABLE 037. EUROPE INFANT FORMULA MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 038. INFANT FORMULA MARKET, BY COUNTRY (2016-2028)
TABLE 039. ASIA PACIFIC INFANT FORMULA MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 040. ASIA PACIFIC INFANT FORMULA MARKET, BY SOURCE (2016-2028)
TABLE 041. ASIA PACIFIC INFANT FORMULA MARKET, BY FORM (2016-2028)
TABLE 042. ASIA PACIFIC INFANT FORMULA MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 043. INFANT FORMULA MARKET, BY COUNTRY (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA INFANT FORMULA MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 045. MIDDLE EAST & AFRICA INFANT FORMULA MARKET, BY SOURCE (2016-2028)
TABLE 046. MIDDLE EAST & AFRICA INFANT FORMULA MARKET, BY FORM (2016-2028)
TABLE 047. MIDDLE EAST & AFRICA INFANT FORMULA MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 048. INFANT FORMULA MARKET, BY COUNTRY (2016-2028)
TABLE 049. SOUTH AMERICA INFANT FORMULA MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 050. SOUTH AMERICA INFANT FORMULA MARKET, BY SOURCE (2016-2028)
TABLE 051. SOUTH AMERICA INFANT FORMULA MARKET, BY FORM (2016-2028)
TABLE 052. SOUTH AMERICA INFANT FORMULA MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 053. INFANT FORMULA MARKET, BY COUNTRY (2016-2028)
TABLE 054. ABBOTT NUTRITION: SNAPSHOT
TABLE 055. ABBOTT NUTRITION: BUSINESS PERFORMANCE
TABLE 056. ABBOTT NUTRITION: PRODUCT PORTFOLIO
TABLE 057. ABBOTT NUTRITION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. THE KRAFT HEINZ COMPANY: SNAPSHOT
TABLE 058. THE KRAFT HEINZ COMPANY: BUSINESS PERFORMANCE
TABLE 059. THE KRAFT HEINZ COMPANY: PRODUCT PORTFOLIO
TABLE 060. THE KRAFT HEINZ COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. NESTLE S. A: SNAPSHOT
TABLE 061. NESTLE S. A: BUSINESS PERFORMANCE
TABLE 062. NESTLE S. A: PRODUCT PORTFOLIO
TABLE 063. NESTLE S. A: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. FRIESLANDCAMPINA N.V. GROUP: SNAPSHOT
TABLE 064. FRIESLANDCAMPINA N.V. GROUP: BUSINESS PERFORMANCE
TABLE 065. FRIESLANDCAMPINA N.V. GROUP: PRODUCT PORTFOLIO
TABLE 066. FRIESLANDCAMPINA N.V. GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. DANONE S.A.: SNAPSHOT
TABLE 067. DANONE S.A.: BUSINESS PERFORMANCE
TABLE 068. DANONE S.A.: PRODUCT PORTFOLIO
TABLE 069. DANONE S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. SYNUTRA INTERNATIONAL INC.: SNAPSHOT
TABLE 070. SYNUTRA INTERNATIONAL INC.: BUSINESS PERFORMANCE
TABLE 071. SYNUTRA INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 072. SYNUTRA INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. MEAD JOHNSON NUTRITION: SNAPSHOT
TABLE 073. MEAD JOHNSON NUTRITION: BUSINESS PERFORMANCE
TABLE 074. MEAD JOHNSON NUTRITION: PRODUCT PORTFOLIO
TABLE 075. MEAD JOHNSON NUTRITION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. MEIJI HOLDINGS CO. LTD.: SNAPSHOT
TABLE 076. MEIJI HOLDINGS CO. LTD.: BUSINESS PERFORMANCE
TABLE 077. MEIJI HOLDINGS CO. LTD.: PRODUCT PORTFOLIO
TABLE 078. MEIJI HOLDINGS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. BEINGMATE BABY & CHILD FOOD CO. LTD.: SNAPSHOT
TABLE 079. BEINGMATE BABY & CHILD FOOD CO. LTD.: BUSINESS PERFORMANCE
TABLE 080. BEINGMATE BABY & CHILD FOOD CO. LTD.: PRODUCT PORTFOLIO
TABLE 081. BEINGMATE BABY & CHILD FOOD CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. PFIZER INC: SNAPSHOT
TABLE 082. PFIZER INC: BUSINESS PERFORMANCE
TABLE 083. PFIZER INC: PRODUCT PORTFOLIO
TABLE 084. PFIZER INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. YILI GROUP: SNAPSHOT
TABLE 085. YILI GROUP: BUSINESS PERFORMANCE
TABLE 086. YILI GROUP: PRODUCT PORTFOLIO
TABLE 087. YILI GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. BELLAMY'S ORGANIC: SNAPSHOT
TABLE 088. BELLAMY'S ORGANIC: BUSINESS PERFORMANCE
TABLE 089. BELLAMY'S ORGANIC: PRODUCT PORTFOLIO
TABLE 090. BELLAMY'S ORGANIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. ARAL FOODS AMBA: SNAPSHOT
TABLE 091. ARAL FOODS AMBA: BUSINESS PERFORMANCE
TABLE 092. ARAL FOODS AMBA: PRODUCT PORTFOLIO
TABLE 093. ARAL FOODS AMBA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 094. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 095. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 096. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. INFANT FORMULA MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. INFANT FORMULA MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. FIRST INFANT FORMULA MARKET OVERVIEW (2016-2028)
FIGURE 013. FOLLOW-ON FORMULA MARKET OVERVIEW (2016-2028)
FIGURE 014. GROWING-UP FORMULA MARKET OVERVIEW (2016-2028)
FIGURE 015. SPECIALTY BABY FORMULA MARKET OVERVIEW (2016-2028)
FIGURE 016. INFANT FORMULA MARKET OVERVIEW BY SOURCE
FIGURE 017. COW MILK MARKET OVERVIEW (2016-2028)
FIGURE 018. SOY MARKET OVERVIEW (2016-2028)
FIGURE 019. PROTEIN HYDROLYSATES MARKET OVERVIEW (2016-2028)
FIGURE 020. GOAT MILK MARKET OVERVIEW (2016-2028)
FIGURE 021. CAMEL MILK MARKET OVERVIEW (2016-2028)
FIGURE 022. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 023. INFANT FORMULA MARKET OVERVIEW BY FORM
FIGURE 024. POWDER MARKET OVERVIEW (2016-2028)
FIGURE 025. LIQUID & SEMI-LIQUID MARKET OVERVIEW (2016-2028)
FIGURE 026. READY-TO-DRINK MARKET OVERVIEW (2016-2028)
FIGURE 027. INFANT FORMULA MARKET OVERVIEW BY DISTRIBUTION CHANNELS
FIGURE 028. HYPERMARKETS/SUPERMARKETS MARKET OVERVIEW (2016-2028)
FIGURE 029. ONLINE STORES MARKET OVERVIEW (2016-2028)
FIGURE 030. PHARMACY/MEDICAL STORES MARKET OVERVIEW (2016-2028)
FIGURE 031. SPECIALTY STORES MARKET OVERVIEW (2016-2028)
FIGURE 032. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 033. NORTH AMERICA INFANT FORMULA MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. EUROPE INFANT FORMULA MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 035. ASIA PACIFIC INFANT FORMULA MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 036. MIDDLE EAST & AFRICA INFANT FORMULA MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 037. SOUTH AMERICA INFANT FORMULA MARKET OVERVIEW BY COUNTRY (2016-2028)